Frost & Sullivan provides an outlook for the global vaccine industry for 2022 and beyond, including emerging trends and growth opportunities. Innovation, which remains mainstream in vaccine development, is augmenting investments by emerging vaccine developers in designing novel technology platforms, especially for nucleic acid-based vaccines. Spurr...

With this research service, Frost & Sullivan’s Healthcare and Life Sciences team provides critical insights into the European Union and UK COVID-19 vaccine and therapeutics market. The report analyzes COVID-19 vaccines and therapeutics in development and delves into supply chain considerations and requirements to manage distribution. Importantly,...

25 Aug 2021  |  Global

Emerging Materials Influence Global Vaccine Packaging: Technology Opportunity Analysis

Need for Better Primary Packaging Materials, Sustainable Options, and Customized Storage during Transport Drives New Product Development

Infographics

×

The materials used for pharmaceutical vaccine packaging vary, and many are well-established in the market for the transport and storage of vaccines. Despite the wide variety, some of the most used vaccine packaging materials remain challenged by glass delamination, instability, and pH alteration over time. The global COVID-19 pandemic has amplified...

This study by Frost & Sullivans Healthcare and Life Sciences team provides critical insights into the US COVID-19 vaccines and therapeutics market, including developing vaccines, supply chain considerations, and requirements to manage distribution. The study also identifies actionable and profitable growth opportunities for industry participants. T...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) discusses multiple developments in vaccine technologies, both prophylactic and therapeutic. Most of the innovations highlighted are around influenza, COVID-19, and cancer vaccines. Developments in intranasal delivery, needle-free delivery, and thermostable formu...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) consists of insights across gene therapies for rare genetic disorders of retina, central nervous system, mitochondrial diseases, hearing disorders, and renal diseases. Therapeutic biomarker for organ anti-aging, next generation cell and gene therapies, drug del...

Influenza causes respiratory diseases and often leads to large epidemics. Every year about 290,000 to 650,000 people die due to influenza worldwide. Anti-viral drugs available to treat influenza have many limitations making vaccination the most effective tool to prevent seasonal and pandemic influenza outbreaks. Influenza vaccination is highly reco...

This edition of the Inside R&D Technology Opportunity Engine (TOE) features information on the use of electronic gloves that convert sign language into speech and the selection of highly selective membranes for the removal of carbon dioxide from industrial processes. The TOE also features the use of brain-computer interface for evaluating spinal c...

This edition of the Inside R&D Technology Opportunity Engine (TOE) features information on development of triple antiviral therapy and a novel vaccine design to stop the spread of corona virus. The TOE also features trends and innovations in artificial intelligence (AI), radiation shielding, and the use of epoxy modified silicone resin coating in a...